Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center. He is a senior oncologist and radiotherapist specializing in digestive system malignancies. He graduated from Hadassah University Hospital in Jerusalem. Dr. Hubert has over 30 years of clinical experience in radiotherapy and oncology.

• Head of the Gastrointestinal Cancer Center at Hadassah.
• Treats complex conditions including pancreatic, colon, and liver cancers.
• Qualified in both medical oncology and radiotherapy.
• Member of the Israel Society of Clinical Oncology and Israel Cancer Association.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Eckhart Weidmann heads the hematology department at Nordwest Clinic. KRAS, NRAS, and BRAF mutation testing helps him determine precise therapy for blood disorders.

• Specializes in treating complex blood cancers and non-Hodgkin lymphoma
• Leads a dedicated department at a major German academic hospital
• Focuses on targeted therapies based on genetic mutation profiles
• Member of the German Society of Hematology and Medical Oncology (DGHO)

Prof. Beni Boursi is a gastrointestinal oncology specialist at Sheba Medical Center. He uses KRAS, NRAS, and BRAF mutation testing for targeted therapy planning.

• Trained in oncology at the University of Pennsylvania and MD Anderson Cancer Center
• Academic scholar at the Perelman School of Medicine in the United States
• Published research on drug responses in patients with BRAF V600 mutations
• Member of the Israeli Association of Clinical Oncology and Radiotherapy
• Researches microbiome interactions to improve how patients respond to cancer treatments

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

The doctor completed specialization training in Radiation Oncology at Marmara University Faculty of Medicine from 2012 to 2016. Prior to this, the doctor completed an undergraduate degree in Medicine, taught in English, at the same institution from 2004 to 2011. The doctor has a strong foundation in medical education, beginning with high school education at Sixteen Numbered Shirvan School in Azerbaijan from 1998 to 2004.

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries. He leads HCG Manavata Cancer Centre, where KRAS, NRAS, and BRAF mutation testing guides surgical planning.

• Completed surgical oncology residency at Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons of Edinburgh
• Participated in over 200 Phase 1–3 clinical trials
• Professor for DNB Superspecialty Surgical Oncology – training future cancer surgeons
• Treats complex cases of liver, pancreatic, and colorectal cancers

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in the molecular basis of cancer and targeted therapies. Dr. Valame completed his DNB training in medical oncology at Indraprastha Apollo Hospital. He previously served as a registrar at Jawaharlal Nehru Cancer Hospital.

• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco.
• Expert in chemotherapy and targeted therapy for breast, lung, and gastrointestinal cancers.
• Treats various solid tumors, pediatric cancers, and hematological malignancies.
• Works at an NABH-accredited center that treats over 75,000 patients annually.

Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.

• Specializes in minimally invasive procedures, including laparoscopy and thoracoscopy.
• Performs robotic cancer surgeries and advanced endoscopic procedures.
• Served as a former assistant professor at the State Cancer Institute.
• Acts as a co-principal investigator for original clinical research projects.
• Treats complex esophageal, stomach, colon, and rectal cancers.

Dr. Antonio Cubillo Gracián heads the Medical Oncology Service at HM CIOCC in Madrid. He provides patients with a pioneering liquid biopsy program in Spain. This blood test identifies molecular characteristics of malignant tumors. Dr. Cubillo Gracián is an Associate Professor at the University CEU San Pablo.

• Directs the postgraduate research Master’s in clinical and applied oncology.
• Leads the Digestive, Sarcomas, and Head and Neck Unit.
• Completed specialized oncology training at the MD Anderson Cancer Center.
• Treats colon cancer, glioblastoma, and pancreatic neuroendocrine tumors.

Dr. Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He specializes in radiation oncology and thermoradiotherapy. He completed a post-doctoral fellowship at Thomas Jefferson University in Philadelphia. Dr. Engin treats complex cases like glioblastoma and stage 4 lung cancer.

• Performs advanced procedures including CyberKnife and targeted radiotherapy.
• Served as Director and Professor at Anadolu Medical Center.
• Former Chairman of the Radiation Oncology Department at Uludağ University.
• Awarded a research scholarship by the US National Cancer Institute (NIH).

Dr. Shruti Kate is a medical oncologist at HCG Manavata Cancer Centre in Nashik. She previously worked as a consultant at the Tata Memorial Hospital in Mumbai. Dr. Kate focuses on immunotherapy and metronomic therapy for treating solid and pediatric tumors. She was the sole recipient from India of the 2018 World Conference on Lung Cancer award.

• Specializes in the treatment of lung, breast, gynecological, and genitourinary cancers.
• Proficient in complex procedures, including the Whipple surgery and chemotherapy management.
• Member of ASCO, ESMO, and the International Association for the Study of Lung Cancer.
• Practices at the NABH-accredited HCG Manavata Cancer Centre.